Joseph F. Nowoslawski
Amministratore Delegato presso JSK Therapeutics, Inc.
Profilo
Joseph F.
Nowoslawski is currently the Chief Executive Officer and Director at JSK Therapeutics, Inc.
Posizioni attive di Joseph F. Nowoslawski
| Società | Posizione | Inizio |
|---|---|---|
JSK Therapeutics, Inc.
 JSK Therapeutics, Inc. BiotechnologyHealth Technology JSK Therapeutics, Inc. develops anti-cancer drugs. It develops novel anti-cancer drugs using an approved compound to inhibit the growth of cancer cells. The company was founded by Thomas Kennedy and Paul J. Shami in 2008 and is headquartered in Salt Lake City, UT. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
JSK Therapeutics, Inc.
JSK Therapeutics, Inc. BiotechnologyHealth Technology JSK Therapeutics, Inc. develops anti-cancer drugs. It develops novel anti-cancer drugs using an approved compound to inhibit the growth of cancer cells. The company was founded by Thomas Kennedy and Paul J. Shami in 2008 and is headquartered in Salt Lake City, UT. | Health Technology |
- Borsa valori
- Insiders
- Joseph F. Nowoslawski
